For localized and limited hair loss, first-line treatment usually involves the use of corticosteroids, which are administered in topical formulations and/or as intralesional injections. Topical minoxidil is another treatment option validated in clinical trials that has been shown to be effective in promoting hair growth in alopecia areata. Among systemic treatment options, oral prednisolone remains a standard choice, but in recent years, oral Janus kinase inhibitors (e.g., baricitinib, ritlecitinib) have significantly expanded the therapeutic arsenal.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Breast (HR+) and Endometrial Cancer
A Comparison of Hormone-Dependent Female Tumors
- Chronic Urticaria: Treatment for Patients Unresponsive to Antihistamines
In addition to anti-IgE antibodies, the guideline recommends anti-IL-4α antibodies and BTK inhibition
- Type 1 Diabetes in Childhood
Early Impairment of Glucagon Counterregulation
- Psychosis in Parkinson's Disease
Be Careful When Choosing Medications
- Esophageal Cancer
A Comparison of Endoscopic and Surgical Innovations
- PMR and LVV: Current EULAR Recommendations
Polymyalgia rheumatica, giant cell arteritis, and Takayasu arteritis
- Cellular and Systemic Iron Homeostasis
“Steady State” – a delicately balanced equilibrium
- Psychedelic-assisted therapy